Advertisement

Chemotherapy or Chemoradiotherapy Followed by Surgical Resection for Non-Small Cell Lung Cancer

  • Nena Mirkovic
  • Kathy S. Albain
Part of the Medical Radiology Radiation Oncology book series (MEDRAD)

Keywords

Clin Oncol Radiat Oncol Biol Phys Induction Regimen Prophylactic Cranial Irradiation Bronchial Stump 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Albain KS, Rusch VW, Crowley JJ, Rice TW, Turrisi AT III, Weick JK, Lonchyna VA, Presant CA, McKenna RJ, Gandara DR, Fosmire H, Taylor AS, Stelzer KJ, Beasley KR, Livingston RB (1995) Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small cell lung cancer. Mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol 13:1880–1892PubMedGoogle Scholar
  2. Albain K, Rusch V, Crowley J, Rice T, Turrisi A, Weick J, Lonchyna V, Presant C, McKenna R, Gandara D, Fosmire H, Taylor S, Stelzer K, Beasley K, Livingston R (1999) Long-term survival after concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery in bulky, stages IIIA(N2) and IIIB non-small cell lung cancer: 6-year outcomes from Southwest Oncolgoy Group study 8805. Proc Amer Soc Clin Oncol 18:467aGoogle Scholar
  3. Albain KS, Rusch V, Turrisi AT, Scott CB, Shepherd FA, Smith C, Gandara DR, Johnson DH, Green MR, Miller RC, Chen Y, Livingston RB, Darling G, Sause WT, Cox JD (2003) Phase III comparison of concurrent chemotherapy plus radiotherapy (CT/RT) and CT/RT followed by surgical resection for stage IIIA(pN2) NSCLC. Initial results from North American Intergroup Trial 0139 (RTOG 9309). Proc Am Soc Clin Oncol, p 621, abstract 2497Google Scholar
  4. Andre F, Grunenwald D, Le Chevalier T (2001) Persistence of viable tumor cells after radiation and chemotherapy for stage IIIB non-small cell lung cancer: an early marker for treatment failure. J Thorac Cardiovasc Surg 121:403CrossRefGoogle Scholar
  5. Antonadou D, Petridis A, Synodinou M, Throuvalas N, Bolanos N, Veslemes M, Sagriotis A (2003) Amifostine reduces radiochemotherapy-induced toxicities in patients with locally advanced non-small cell lung cancer. Semin Oncol 30[Suppl 18]:2–9CrossRefGoogle Scholar
  6. Arriagada R, Le Chevalier T, Quoix E, Ruffie P, de Cremoux H, Douillard J-Y, Tayare M, Pignon J-P, LaPlanche A (1991) Astro plenary: effect of chemotherapy on locally advanced non-small cell lung carcinoma: a randomized study of 353 patients. Int J Radiat Oncol Biol Phys 20:1183–1190PubMedGoogle Scholar
  7. Arriagada R, Bergman B, Dunant A, Le Chevalier T, Pignon JP, Vansteenkiste J, International Adjuvant Lung Cancer Trial Collaborative Group (2004) Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 350:351–360CrossRefPubMedGoogle Scholar
  8. Betticher DC, Schmitz S-F H, Totsch M, Hansen E, Joss C, von Briel C, Schmid RA, Pless M, Habicht J, Roth AD, Spiliopoulos A, Stahel R, Weder W, Stupp R, Egli F, Furrer M, Honegger H, Wernli M, Cerny T, Ris H-B (2003) Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: A multi-center phase II trial. J Clin Oncol 21:1752–1759CrossRefPubMedGoogle Scholar
  9. Bitran JD, Golomb HM, Hoffman PC, Albain K, Evans R, Little AG, Purl S, Skosey C (1986) Protochemotherapy in non-small cell lung carcinoma. Cancer 57:44–53PubMedGoogle Scholar
  10. Burkes R, Ginsberg RJ, Shepherd FA, Blackstein ME, Goldberg ME, Waters PE, Patterson GA, Pearso FG, Cooper JD et al (1992) Induction chemotherapy with mitomycin, vindesine and cisplatin for stage III unresectable non-small cell lung cancer: results of the Toronto Phase II trial. J Clin Oncol 10:580–586PubMedGoogle Scholar
  11. Cappuzzo F, Selvaggi G, Gregorc V, Mazzoni F, Betti M, Migliorino MR, Novello S, Maestri A, De Marinis F, Darwish S, de Angelis V, Nelli F, Bartolini S, Scagliotti GV, Tonato M, Crino L (2003) Gemcitabine and cisplatin as induction chemotherapy for patients with unresectable Stage IIIA-bulky N2 and Stage IIIB nonsmall cell lung carcinoma: an Italian Lung Cancer Project Observational Study. Cancer 98:128–134CrossRefPubMedGoogle Scholar
  12. Choi NC, Carey RW, Daly W, Mathisen D, Wain J, Wright C, Lynch T, Grossbard M, Grillo H (1997) Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small cell lung cancer. J Clin Oncol 15:712–722PubMedGoogle Scholar
  13. Cox JD, Pajak TF, Asbell S, Russell AH, Pederson J, Byhardt RW, Emami B, Roach M 3rd (1993) Interruptions of high-dose radiation therapy decrease long-term survival of favorable patients with unresectable non-small cell carcinoma of the lung: analysis of 1244 cases from 3 Radiation Therapy Oncology Group (RTOG) trials. Int J Radiat Oncol Biol Phys 27:493–498PubMedGoogle Scholar
  14. Darwish S, Minotti V, Crino L, Rossetti R, Maranzano E, Checcaglini F, Fiaschini P, Mercati U, Penza O, Vitali R, Davis S, Latini P, Tonato M (1994) Neoadjuvant cisplatin and etoposide for stage IIIA (Clinical N2) non-small cell lung cancer. Am J Clin Oncol 17:64–67PubMedGoogle Scholar
  15. De Marinis F, Nelli F, Migliorino MR, Martelli O, Cortesi E, Treggiari S, Portalone L, Crispino C, Brancaccio L, Gridelli C (2003) Gemcitabine, paclitaxel and cisplatin as induction hemotherapy for patients with biopsy-proven stage III (N2) non-small cell lung carcinoma. A phase II multicenter study. Cancer 98:1707–1715CrossRefPubMedGoogle Scholar
  16. Depierre A, Milleron B, Moro-Sibilot D, Chevret S, Quoix E, Lebeau B, Braun D, Breton JL, Lemarie E, Gouva S, Paillot N, Brechot JM, Janicot H, Lebas FX, Terrioux P, Clavier J, Foucher P, Monchatre M, Coetmeur D, Level MC, Leclerc P, Blanchon F, Rodier JM, Thiberville L, Villeneuve A, Westeel V, Chastang C, French Thoracic Cooperative Group (2002) Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer. J Clin Oncol 20:247–253CrossRefPubMedGoogle Scholar
  17. Deslauriers J, Aucoin A, Gregoire J (1998) Postpneumonectomy pulmonary edema. Chest Surg Clin North Am 8:611Google Scholar
  18. Deutsch M, Crawford J, Leopold K, Wolfe W, Foster W, Herndon J, Blackwell S, Yost R (1994) Phase II Study of neoadjuvant chemotherapy and radiation therapy in the treatment of clinically staged IIIA non-small cell lung cancer. Cancer 74:1243–1252PubMedGoogle Scholar
  19. Dillman RO, Herndon J, Seagren SL, Eaton WL Jr, Green MR (1996) Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial. J Natl Cancer Inst 88:1210–1215PubMedGoogle Scholar
  20. Eagan RT, Ruud C, Lee RE, Pairolero PC, Gail MH (1987) Pilot study of induction therapy with cyclophosphamide, doxorubicin and cisplatin (CAP) and chest irradiation prior to thoracotomy in initially inoperable stage III MO non-small cell lung cancer. Cancer Treat Rep 71:895–900PubMedGoogle Scholar
  21. Eberhardt W, Wilke H, Stamatis G, Stuschke M, Harstrick A, Menker H, Krause B, Mueller MR, Stahl M, Budach V, Greschuchna D, Konietzko N, Sack H, Seeber S (1998) Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small cell lung cancer: mature results of a phase II trial. J Clin Oncol 16:622–634PubMedGoogle Scholar
  22. Eberhardt WE, Albain KS, Pass HI, Putnam JB, Gregor A, Assamura H, Mornex F, senan S, Belderbos J, Westeel V, Thomas M, van Schil P, Vansteenkiste J, Manegold C, Mirimanoff RO, Stuschke M, Pignon J, Rocmans P, Shepher FA (2003) Induction treatment before surgery for non-small cell lung cancer. Lung Cancer [Suppl] 42:9–4CrossRefPubMedGoogle Scholar
  23. Elias AD, Skarin AT, Gonin R, Oliynyk P, Stomper PC, O'Hara C, Socinski A, Sheldon T, Maggs P, Frei E (1994) Neoadjuvant treatment of stage IIIA non-small cell lung cancer. Am J Clin Oncol 17:26–36PubMedGoogle Scholar
  24. Elias AD, Skarin AT, Leong T, Mentzer S, Strauss G, Lynch T, Shulman L, Jacobs C, Abner A, Baldini AH, Frei E, Sugarbaker DJ (1997) Neoadjuvant therapy for surgically staged IIIA N2 non-small cell lung cancer (NSCLC). Lung Cancer 17:147–161CrossRefPubMedGoogle Scholar
  25. Elias AD, Kumar P, Hernon J III, Skarin AT, Sugarbaker DJ, Green MR (2002) Radiotherapy versus chemotherapy plus radiotherapy in surgically treated IIIA non-small-cell lung cancer. Clin Lung Cancer 4:95–103PubMedGoogle Scholar
  26. Faber LP, Kittle FC, Warren WH, Bonomi PD, Taylor SG IV, Reddy S, Lee MS (1989) Preoperative chemotherapy and irradiation for stage III non-small cell lung cancer. Ann Thorac Surg 47:669–677PubMedGoogle Scholar
  27. Faber LP, Piccione W (2000) Complications of surgery. In: Pass HI, Mitchell JB, Johnson DH, Turrisi AT, Minna JD (eds) Lung cancer. Principles and practice, chap 41, 2nd edn. Lippincott Williams and Wilkins, Philadelphia, pp 743–765Google Scholar
  28. Fleck J, Camargo J, Godoy D et al (1994) Chemoradiation therapy versus chemotherapy alone as a neoadjuvant treatment for stage III non-small cell lung cancer. Preliminary report of a phase III prospective randomized trial. Proc Am Soc Clin Oncol 12:333Google Scholar
  29. Fowler WC, Langer CJ, Curran WJ Jr, Keller SM (1993) Postoperative complications after combined neoadjuvant treatment of lung cancer. Ann Thorac Surg 55:986–989PubMedGoogle Scholar
  30. Ginsberg RJ, Hill LD, Eagen RT et al (1983) Modern thirty day operative mortality for surgical resections in lung cancer. J Thorac Cardiovasc Surg 86:654PubMedGoogle Scholar
  31. Gopal R, Starkschall G, Tucker S, Liao Z, Kelly J, Stevens C, Komaki R (2001) The effects of radiation therapy, chemotherapy and the radioprotector amifostine on the diffusion capacity of patients with non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 51Google Scholar
  32. Gopal R, Tucker SL, Komaki R, Liao Z, Forster KM, Stevens C, Kelly JF, Starkschall (2003) The relationship between local dose and loss of function for irradiated lung. Int J Radiat Oncol Biol Phys 56:106–113PubMedGoogle Scholar
  33. Graham MV, Purdy JA, Emami B, Harms W, Bosch W, Lockett MA, Perez CA (1999) Clinical Dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys; 45:323–329CrossRefPubMedGoogle Scholar
  34. Grunenwald DH, Andre F, Le Pechoux C, Girard P, Lamer C, Laplanche A, Tarayre M, Arriagad R, Le Chevalier T (2001) Benefit of surgery after chemoradiotherapy in stage IIIB (T4 and/or N3) non-small cell lung cancer. J Thorac Cardiovasc Surg 122:796–802CrossRefPubMedGoogle Scholar
  35. Hamada C, Ohta M, Wada H, Fujimura S, Kodama K, Imaizumi M, Nakanishi YH, Matsuoka N (2004) Survival benefit of oral UFT for adjuvant chemotherapy after completely resected non-small cell lung cancer. Proc Am Soc Clin Oncol 23:615Google Scholar
  36. Harpole DH, Liptay MJ, DeCamp MM et al (1996) Prospective analysis of pneumonectomy: risk factors for major morbidity and cardiac dysrhythmias. Ann Thorac Surg 61:977CrossRefPubMedGoogle Scholar
  37. Jeremic B, Shibamoto Y, Milicic B, Dagovic A, Nikolic N, Aleksandrovic J, Acimovic L, Milisavljevic S (2003) Impact of treatment interruptions due to toxicity on outcome of patients with early stage (I/II) non-small-cell lung cancer (NSCLC) treated with hyperfractionated radiation therapy alone. Lung Cancer 40:317–323PubMedGoogle Scholar
  38. Johnstone DW, Byhardt RW, Ettinger D, Scott CB (2002) Phase III study comparing chemotherapy and radiotherapy with preoperative chemotherapy and surgical resection in patients with non-small cell lung cancer with spread to mediastinal lymph nodes (N2); final report of RTOG 89-01. Int J Radiat Oncol Biol Phys 54:365–369CrossRefPubMedGoogle Scholar
  39. Kumar P, Herndon J, Langer M, Kohman LJ, Elias AD, Kass FC, Eaton WL, Seagren SL, Green MR, Sugarbaker DJ (1996) Patterns of failure after trimodality therapy of non-small cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935. Cancer 77:2393–2399CrossRefPubMedGoogle Scholar
  40. Liptay MJ, Fry WA (1999) Surgical complications from induction regimens for thoracic malignancies. Chest Surg Clin North Am 9:70–95Google Scholar
  41. Marks LB, Munley MT, Spencer DP et al (1997) Quantification of radiation-induced regional lung injury with perfusion imaging. Int J Radiat Oncol Biol Phys 38:399–409CrossRefPubMedGoogle Scholar
  42. Martini N, Kris MG, Fehinger BJ, Gralla RJ, Bains MS, Burt ME, Heelan R, McCormack PM, Pisters KMW, Rigas JR, Rusch VW, Ginsberg RJ (1993) Preoperative chemotherapy for stage IIIa (N2) lung cancer: the Sloan Kettering experience with 136 patients. Ann Thor Surg 55:1365–1374Google Scholar
  43. Mitsudomi T, Mizoue T, Yoshimatsu T et al (1996) Postoperative complications after pneumonectomy for treatment of lung cancer: multivariate analysis. J Surg Oncol 61:218CrossRefPubMedGoogle Scholar
  44. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (2004) Non-small-cell lung cancer. J Natl Compreh Cancer Network 2:102–103Google Scholar
  45. O'Brien ME, Splinter T, Smit EF, Biesma B, Krzakowski M, Tjan-Heijnen VC, van Bochove A, Stigt J, Smid-Geirnaerdt MJ, Debruyne C, Legrand C, Giaccone G, EORTC Lung Cancer Group (2003) Carboplatin and paclitaxol (Taxol) as an induction regimen for patients with biopsy-proven stage IIIA N2 non-small cell lung cancer. An EORTC phase II study (EORTC 08958). Eur J Cancer 39:1416–1422CrossRefPubMedGoogle Scholar
  46. Pass HI, Pogrebniak H, Steinberg SM, Mulshine J, Minna J (1992) Randomized trial of neoadjuvant therapy for lung cancer: interim analysis. Ann Thorac Surg 53:992–998PubMedGoogle Scholar
  47. Pisters K, Ginsberg RJ, Giroux DJ, Putnam JB Jr, Kris MG, Johnosn DH, Roberts JR, Mault J, Crowley JJ, Bunn PA (2000) Induction chemotherapy before surgery for early stage lung cancer: a novel approach. J Thorac Cardiovasc Surg 119:429–439CrossRefPubMedGoogle Scholar
  48. Pisters K, Ginsberg R, Giroux D, Kris M, Putnam JB, Roberts JR, Johnson D, Crowley J, Bunn PA (2003) Bimodality lung oncology team(BLOT) trial of induction paclitaxel/carboplatin in early stage non-small cell lung cancer (NSCLC): long-term follow-up of a phase II study. Proc Am Soc Clin Oncol abstract no 2544Google Scholar
  49. Pitz CCM, Maas KW, van Swieten HA, Brutel de la Riviere A, Hofman P, Schramel FMNH (2002) Surgery as a part of combined modality treatment in stage IIIB non-small cell lung cancer. Ann Thorac Surg 74:164–169CrossRefPubMedGoogle Scholar
  50. Reddy S, Lee MS, Bonomi P, Taylor SG IV, Kaplan E, Gale M, Faber LP, Warren W, Kittle CG, Hendrickson FR (1992) Combined modality therapy for stage III non-small cell lung carcinoma: results of treatment and patterns of failure. Int J Radiat Oncol Biol Phys 24:17–23PubMedGoogle Scholar
  51. Rosell R, Gomez-Codina J, Camps C, Maestre J, Canto A, Mate JL, Li S, Roig J, Olazabal A, Ariza A, Skacel Z, Morera-Prat J, Abad A (1994) A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell-lung cancer. N Engl J Med 330:153–158PubMedGoogle Scholar
  52. Roth JA, Atkinson EN, Fossella F, Komaki R, Ryan MB, Putnam JB Jr, Lee JS, Dhingra H, de Caro L, Chasen M, Hong WK (1998) Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small cell lung cancer. Lung Cancer 21:1–6CrossRefPubMedGoogle Scholar
  53. Roth JA, Fossella F, Komaki R, Ryan MB, Putnam JB, Lee JS, Dhingra H, de Caro L, Chasen M, McGavran M, Atkinson CN, Hong WK (1994) A randomized trial comparing preoperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small cell lung cancer. J Natl Cancer Inst 86:673–680PubMedGoogle Scholar
  54. Sause W, Kolesar P, Taylor S IV, Johnson D, Livingston R, Komaki R, Emami B, Curran W Jr, Byhardt R, Dar AR, Turrisi A 3rd (2000) Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group. Chest 117:358–364CrossRefPubMedGoogle Scholar
  55. Schumacher A, Riesenbeck D, Braunheim M, Wewers D, Heinecke A, Semik M, Hoffknecht, Macha HN, Klinke F, Schmid E-W, Willich N, Berdel W, Thomas M (2004) Combined modality treatment for locally advanced non-small cell lung cancer: preoperative chemoradiation does not result in a poorer quality of life. Lung Cancer 44:89–87CrossRefPubMedGoogle Scholar
  56. Seppenwoolde Y, Muller SH, Theuws JC et al (2000) Radiation dose-effect relations and local recovery in perfusion for patients with non-small cell lung cancer. Int J Radiat Oncol Biol Phys 47:681–690PubMedGoogle Scholar
  57. Shepherd FA, Johnston MR, Burkes R, Deslauriers J, de Bedoya LD, Ottaway J, James K, Zee B (1998) Randomized study of chemotherapy and surgery versus radiotherapy for stage IIIA non-small-cell lung cancer. A National Cancer Institute of Canada Clinical Trials Group study. Br J Cancer 78:683–685PubMedGoogle Scholar
  58. Skarin A, Jochelson M, Sheldon T, Malcolm A, Oliynyk P, Overholt R, Hunt M, Frei E (1989) Neoadjuvant chemotherapy in marginally resectable stage III MO Non-small cell lung cancer: long-term follow-up in 41 patients. J Surg Oncol 40:266–274PubMedGoogle Scholar
  59. Splinter TAW, van Schil PE, Kramer GWPM, van Meerbeeck J, Gregor A, Rocmans P, Kirkpatrick A (2000) Randomized trial of surgery versus radiotherapy in patients with stage IIIA (N2) Non-small-cell lung cancer after a response to induction chemotherapy. EORTC 08941. Clin Lung Cancer 2:69–72PubMedGoogle Scholar
  60. Strauss GM, Herndon J, Maddaus MA, Johnstone DW, Johnson EA, Watson DM, Sugarbaker DJ, Schilsky RL, Green ML (2004) Randomized clinical trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in stage IB non-small cell lung cancer: report of Cancer and Leukemia Group B protocol 9633. Proc Am Soc Clin Oncol 23 late-breaking abstract 7019Google Scholar
  61. Strauss GM, Herndon JE, Sherman DD, Mathisen DJ, Carey RW, Choi NC, Rege VB, Modeas C, Green MR (1992) Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small cell carcinoma of the lung: report of a Cancer and Leukemia Group B phase II study. J Clin Oncol 10:1237–1244PubMedGoogle Scholar
  62. Sugarbaker DJ, Herndon J, Kohman LJ, Krasna MJ, Green MR (1995) Results of cancer and leukemia group B protocol 8935. A multiinstitutional phase II trimodality trials for stage IIIa (N2) non-small cell lung cancer. J Thor Cardiovasc Surg 109:473–485CrossRefGoogle Scholar
  63. Thomas M, Macha HN, Ukena D, Hamm M, Deppermann M, Semik M, Riesenbeck D, Rube C, Heinecke A (2004) Cisplatin/etoposide (PE) followed by twice-daily chemoradiation versus PE alone before surgery in stage III non-small cell lung cancer. A randomized phase III trial of the German Lung Cancer Coopertive Group (GLCCG). Proc Am Soc Clin Oncol 23:616 (abstract 7004)Google Scholar
  64. Thomas M, Rube C, Semik M, von Eiff M, Freitag L, Macha HN, Wagner W, Klinke F, Scheld H, Willich N, Berdel E, Junker K (1999) Impact of preoperative bimodality induction including twice-daily radiation on tumor regression and survival in stage III non-small cell lung cancer. J Clin Oncol 17:1185–1193PubMedGoogle Scholar
  65. Van Zandwijk N, Smit EF, Kramer GW, Schramel F, Gans S, Festen J, Termeer A, Schlosser NJ, Debruyne C, Curran D, Giaccone G (2000) Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955). J Clin Oncol 18:2658–2664PubMedGoogle Scholar
  66. Vora SA, Daly BDT, Blaszkowsky L, McGrath JJ, Bankoff M, Supran S, Dipetrillo TA (2000) High dose radiation therapy and chemotherapy as induction treatment for stage III non-small cell lung carcinoma. Cancer 89:1946–1952CrossRefPubMedGoogle Scholar
  67. Wagner H, Lad T, Piantadosi S Ruckdeschel JC for the Lung Cancer Study Group (1994) Randomized phase II evaluation of preoperative radiation therapy and preoperative chemotherapy with mitomycin, vinblastine and cisplatin in stage IIIA and IIIB non-small cell lung cancer. LCSG 881. Chest 106:348S–354SPubMedGoogle Scholar
  68. Warram J (1975) Preoperative irradiation of cancer of the lung: final report of a therapeutic trial. A collaborative study. Cancer 36:914–925PubMedGoogle Scholar
  69. Weiden PL, Piantadosi S (1992) Preoperative chemotherapy (cisplatin and fluorouracil) and radiation therapy in stage III non-small cell lung cancer: a phase II study of the lung cancer study group. J Natl Cancer Inst 83:266–272Google Scholar
  70. Winton TL, Livingston R, Johnson D, Rigas J, Cormier Y, Butts C, Ding K, Seymour L, Magoski N, Shepherd F (2004) A prospective randomized trial of adjuvant vinorelbine and cisplatin in completed resected stage IB and II non-small cell lung cancer. Intergroup JBR.10. Proc Amer Soc Clin Oncol 23 late-breaking abstract 7018Google Scholar
  71. Yashar J, Weitberg AB, Glicksma AS, Posner MR, Feng W, Wanebo HJ (1992) Preoperative chemotherapy and radiation therapy for stage IIIA carcinoma of the lung. Ann Thorac Surg 53:445–448PubMedGoogle Scholar
  72. Yoneda S, Hibino S, Gotoh I et al (1995) A comparative trial on induction chemoradiotherapy followed by surgery or immediate surgery for stage III NSCLC. Proc Am Soc Clin Oncol 14:367Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Authors and Affiliations

  • Nena Mirkovic
    • 1
  • Kathy S. Albain
    • 2
  1. 1.Department of Radiation Oncology, Stritch School of MedicineLoyola University ChicagoMaywoodUSA
  2. 2.Department of Medicine, Division of Hematology/Oncology, Stritch School of MedicineLoyola University ChicagoMaywoodUSA

Personalised recommendations